Ozempic and Mounjaro: The Weight Loss Benefits of GLP-1 Agonists

The GLP-1 agonist drugs, Ozempic and Mounjaro, have gained significant attention for their ability to not only treat diabetes but also cause significant and sustained weight loss. This remarkable effect can be attributed to their impact on incretin hormones, specifically glucagon-like peptide-1 (GLP-1).

GLP-1 is a hormone released by the intestine in response to food intake. It plays a crucial role in regulating blood sugar levels by stimulating insulin secretion and inhibiting glucagon release. Additionally, GLP-1 slows down gastric emptying, leading to increased satiety and reduced appetite.

Ozempic and Mounjaro are designed to mimic the actions of GLP-1. When these drugs are administered, they bind to GLP-1 receptors in different parts of the body, including the pancreas, brain, and stomach. By activating these receptors, they enhance the effects of GLP-1, resulting in several beneficial outcomes.

One of the primary effects is the promotion of insulin secretion from pancreatic beta cells. This leads to improved glucose uptake by cells and a decrease in blood sugar levels. Additionally, GLP-1 agonists suppress the release of glucagon, which is responsible for increasing blood sugar levels. By blunting glucagon’s action, these drugs help maintain a more stable glucose balance.

In regards to weight loss, GLP-1 agonists exert multiple effects. They delay gastric emptying, which means food stays in the stomach for a longer duration, creating a feeling of fullness and reducing the urge to eat. Moreover, GLP-1 agonists act on the hypothalamus in the brain, helping to regulate appetite and satiety signals.

Furthermore, GLP-1 agonists increase energy expenditure and promote fat burning. They enhance the breakdown of stored fat while simultaneously decreasing the absorption of fat from the gastrointestinal tract. These combined mechanisms contribute to substantial weight loss over time.

It is worth noting that the weight loss achieved with GLP-1 agonist drugs varies from person to person. However, studies have demonstrated that patients using Ozempic or Mounjaro experience more significant weight loss compared to other diabetes medications.

In conclusion, the GLP-1 agonist drugs, such as Ozempic and Mounjaro, are effective treatments for diabetes while also offering the substantial benefit of promoting significant and sustained weight loss. By influencing incretin hormones, these medications provide a comprehensive approach to managing both blood sugar levels and body weight.

Study Shows Weight-Loss Drugs Benefit Kidney Function

Recent studies show that GLP-1 receptor agonists, like semaglutide, significantly improve kidney health, with findings indicating a 16% reduction in kidney failure risk and benefits observed in both diabetic and non-diabetic individuals. These results are supported by extensive clinical trials, although further research is suggested to clarify the relationship between weight loss and kidney function improvements.

Weight-loss drugs can improve kidney health, study finds. is true? are the finding convincing

Recent studies have indeed found compelling evidence that weight-loss drugs, particularly GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), can improve kidney health. The findings are convincing for several reasons:

Comprehensive Clinical Trials

A meta-analysis of 11 large-scale clinical trials involving 85,373 participants provided robust evidence of the kidney-protective effects of GLP-1 receptor agonists[2]. This extensive dataset lends significant credibility to the findings.

Specific Kidney Health Improvements

The studies demonstrated several key benefits for kidney health:

  • 16% reduction in the risk of kidney failure[2][4]
  • 22% reduction in the risk of worsening kidney function[2][4]
  • 19% combined reduction in the risk of kidney failure, worsening kidney function, and death due to kidney disease[2]

Benefits Beyond Diabetes

Importantly, these kidney health improvements were observed in people both with and without diabetes[2][3]. This suggests that the benefits extend beyond diabetes management and may be applicable to a broader population.

Mechanism of Action

The kidney-protective effects of GLP-1 receptor agonists are likely due to a combination of factors:

  • Weight loss, which reduces stress on organs, including the kidneys[1]
  • Improved blood sugar control
  • Reduced inflammation associated with obesity[1]

Additional Cardiovascular Benefits

The studies also confirmed cardiovascular benefits, including:

  • 14% reduction in the risk of cardiovascular death, non-fatal heart attack, and non-fatal stroke[2]
  • 13% lower risk of death from any cause[2][4]

These cardiovascular improvements are particularly relevant for kidney health, as cardiovascular disease is a major risk factor for kidney problems.

Expert Opinions

Leading researchers and medical professionals have expressed confidence in these findings:

  • Prof. Helen M. Colhoun from the University of Edinburgh stated that semaglutide “may contribute to a significant reduction in the risk of kidney-related complications”[1]
  • Dr. Sunil Badve, lead author of a major study, emphasized the clear benefit of GLP-1 receptor agonists on kidney failure and end-stage kidney disease[2]

While these findings are convincing, it’s worth noting that some researchers suggest further investigation is needed to determine if the kidney function improvement is independent of weight loss[1]. Additionally, a comparison study found that bariatric surgery may be even more effective than GLP-1 drugs for preserving kidney function in people with obesity and type 2 diabetes[5].

In conclusion, the evidence strongly supports the claim that weight-loss drugs, particularly GLP-1 receptor agonists, can improve kidney health. The findings are based on large-scale, well-designed studies and are corroborated by multiple research teams, making them highly convincing.

Citations:
[1] Semaglutide use tied to lower kidney disease risk in obesity https://www.medicalnewstoday.com/articles/drugs-like-ozempic-could-protect-kidney-health-in-people-with-heart-disease-obesity
[2] Popular diabetes and obesity drugs also protect kidneys, study shows https://medicalxpress.com/news/2024-11-popular-diabetes-obesity-drugs-kidneys.html
[3] Weight loss drugs could help fight chronic kidney disease, study finds https://www.euronews.com/health/2024/11/26/weight-loss-drugs-could-help-fight-chronic-kidney-disease-study-finds
[4] Study Finds GLP-1 Meds Can Also Help the Kidneys https://www.usnews.com/news/health-news/articles/2024-11-26/study-finds-glp-1-meds-can-also-help-the-kidneys
[5] Obesity: Bariatric surgery better than GLP-1 drugs for kidney health https://www.medicalnewstoday.com/articles/weight-loss-surgery-may-preserve-kidney-health-more-effectively-than-glp-1-drugs

Long-Term Side Effects of Ozempic

Ozempic (semaglutide) is a medication commonly prescribed to help manage type 2 diabetes. While it is generally considered safe and effective when used as directed, like any medication, it may have potential side effects. Here are some of the long-term side effects that have been reported with the use of Ozempic:

  1. Kidney Problems: In rare cases, Ozempic has been associated with kidney problems, including kidney failure. It’s important to monitor your kidney function regularly when taking this medication.
  2. Thyroid Cancer: There have been reports of thyroid cancer in animal studies with semaglutide, the active ingredient in Ozempic. However, no clear link has been established with humans at this time. As a precaution, it is recommended to inform your healthcare provider if you have a personal or family history of thyroid cancer before starting Ozempic.
  3. Pancreatitis: Although rare, pancreatitis (inflammation of the pancreas) has been reported with the use of Ozempic. Symptoms may include severe abdominal pain, nausea, and vomiting. Contact your doctor immediately if you experience these symptoms.
  4. Gallbladder Disease: Some individuals taking Ozempic may develop gallbladder-related problems, such as gallstones or inflammation of the gallbladder. Seek medical attention if you experience abdominal pain, especially if it is accompanied by fever or jaundice.
  5. Allergic Reactions: In rare cases, allergic reactions to Ozempic may occur. Symptoms can include rash, itching, swelling, severe dizziness, or difficulty breathing. If you experience any of these symptoms, seek immediate medical attention.

It is essential to discuss any concerns or potential side effects with your healthcare provider. They will be able to provide you with personalized information and guidance based on your specific health situation.

Side effects of injections for weight loss. How to reduce them?

Injections for weight loss, also known as slimming injections, can have various side effects. It’s important to note that these injections should always be administered by a qualified healthcare professional. Here are some common side effects and suggestions to reduce or manage them:

Long-Term Side Effects of Ozempic

  1. Nausea and Vomiting: These digestive side effects can occur due to the medication’s effect on your gastrointestinal system. To reduce nausea, it’s advisable to eat small, frequent meals and avoid heavy or spicy foods. Taking anti-nausea medication under medical supervision may also help.
  2. Diarrhea or Constipation: Digestive disturbances like diarrhea or constipation can be experienced as a result of slimming injections. Staying hydrated, consuming a balanced diet rich in fiber, and increasing physical activity can aid in regulating bowel movements. If the issue persists, consult with a healthcare professional.
  3. Headaches and Dizziness: Some individuals may experience headaches or dizziness when using slimming injections. Ensuring adequate hydration, rest, and managing stress levels might potentially alleviate these symptoms. However, it’s essential to consult your healthcare provider if these side effects persist or worsen.
  4. Injection Site Reactions: Injection site reactions such as pain, redness, or swelling may occur. Applying a cold compress to the area or gentle massage can help alleviate these symptoms. If the reaction worsens or if you observe any signs of infection, seek medical attention immediately.
  5. Mood Changes and Sleep Disturbances: In some cases, slimming injections may lead to mood swings or disruptions in sleep patterns. Engaging in relaxation techniques, regular exercise, and maintaining a stable sleep routine can potentially mitigate these side effects. If severe or persistent, consult your healthcare provider.

It’s important to remember that individual reactions to slimming injections may vary. Before considering any treatment, it is crucial to consult with a qualified healthcare professional who can assess your specific needs, medical history, and guide you accordingly. Slimming injections should be used under medical supervision and in conjunction with a comprehensive weight loss plan comprising of a healthy diet and regular exercise.

What happens to the face after the Ozempic?

Some of the side effects of slimming injections, like the well-known drug Ozempic, are not listed in the leaflet. Some users of the medication observe a definite sagging of the facial skin. The term for this is Ozempic face syndrome. These people appear older and more serious as a result. What causes this symptom, and how can it be lessened?

Ozempic (semaglutide) is a very well-known prescription drug that is used to treat type 2 diabetes. Studies show that the supplement is effective at lowering body weight (by almost 15% on average) and controlling blood sugar. It is widely used because of this all over the world. However, it turns out that losing weight quickly comes at a cost, which is visible on the face. Thankfully, there is a fix for that. Specialists advise using a range of techniques, from professional invasive procedures to simple and accessible non-invasive ones.

see also : How does oral Semaglutide differ from an injectable weight loss drug?

Slimming injections : Do they work?

What is an “Ozempic face”?

“Ozempic face” is the sagging of the facial skin as a result of using Ozempic to lose weight and body fat quickly. Some patients say that as the treatment goes on, their wrinkles get deeper and their faces look thinner, which could make them look older and more serious. This unfavourable weight loss effect happens particularly when weight loss takes place quickly, as it frequently does with injectable semaglutide.

“Ozempic face” — a new term, a known problem.

According to the New York Times, a New York dermatologist coined the phrase “Ozempic face” after patients whose facial skin sagged after taking the drug asked him about it. In actuality, this issue is not brand new. Any weight loss method that produces quick results usually causes the skin to sag and the facial features to tighten. This results from the loss of adipose tissue, which serves as our body’s natural filler, as well as nutrient deprivation, skin thinning, and elasticity loss. The skin becomes more flaccid as a result of the disruption in the metabolism of collagen and elastin.

The Ozempic Face: How to Deal with It?

Specialists in the so-called different methods are recommended for the ozempic face. To reduce wrinkles and improve skin firmness, we can use simple methods on our own.

  • drinking plenty of fluids.
  • a healthy, balanced diet rich in fruits and vegetables,
  • skin protection against solar radiation,
  • Skin preparations with retinol,
  • daily moisturising of the face skin,
  • peelings,
  • regular facial massage.

Professional treatments that improve facial firmness and give a rejuvenating effect include:

  • filling wrinkles (e.g., with own fat or hyaluronic acid),
  • face firming with radio waves, 
  • infrared radiation therapy,
  • needle and needleless mesotherapy,
  • chemical peels.

The selection of the appropriate method for us should be discussed with a dermatologist or specialist in aesthetic medicine. It is worth remembering about proper face care and healthy eating while using Ozempic. Thanks to this, the risk that the effects visible on the face will be unsatisfactory for us will be smaller.